| 1 | 1270138-40-3 | [2-[(3-甲基丁基)氨基]-3-吡啶基][4-(苯基甲基)-1-哌嗪基]甲酮 | NSI-189 | C22H30N4O
| 原料;定做;化合物;保健品添加剂;小分子抑制剂;小分子抑制剂，天然产物 | |
| 2 | 34851-48-4 | [bis[4-(dimethylamino)phenyl]methylene]butylurea | [bis[4-(dimethylamino)phenyl]methylene]butylurea | C22H30N4O
| | |
| 3 | | [[(2S)-1-Methyl-2-pyrrolidinyl]methyl](2-pyridinyl) ether | [[(2S)-1-Methyl-2-pyrrolidinyl]methyl](2-pyridinyl) ether | C22H30N4O
| | |
| 4 | | N-(2-Dimethylaminoethyl)-4-diphenylmethylpiperazine-1-carboxamide | N-(2-Dimethylaminoethyl)-4-diphenylmethylpiperazine-1-carboxamide | C22H30N4O
| | |
| 5 | 61502-73-6 | | 1,1,3,3-Cyclohexanetetrapropanenitrile, 5-(1,1-dimethylethyl)-2-oxo- | C22H30N4O
| | |
| 6 | 431926-77-1 | 1-(2-methoxyphenyl)-4-[1-(pyridin-3-ylmethyl)piperidin-4-yl]piperazine | 1-(2-methoxyphenyl)-4-[1-(pyridin-3-ylmethyl)piperidin-4-yl]piperazine | C22H30N4O
| | |
| 7 | | N'-[2-(2,4-DIMETHYL-9H-PYRIDO[2,3-B]INDOL-9-YL)ETHYL]-N,N-DIISOPROPYLUREA | N'-[2-(2,4-DIMETHYL-9H-PYRIDO[2,3-B]INDOL-9-YL)ETHYL]-N,N-DIISOPROPYLUREA | C22H30N4O
| | |
| 8 | 75821-80-6 | 2-[(4-ETHOXYPHENYL)METHYL] | 1H-Benzimidazole-1-ethanamine, 5-amino-2-[(4-ethoxyphenyl)methyl]-N,N-diethyl- | C22H30N4O
| | |
| 9 | 1648909-73-2 | Bis-Imidazole phenol IDH1 inhibitor >=98% (HPLC), solubility: 30 mg/mL in DMSOclear | Bis-Imidazole phenol IDH1 inhibitor >=98% (HPLC), solubility: 30 mg/mL in DMSOclear | C22H30N4O
| | |
| 10 | 515175-53-8 | 4-tert-butyl-N'-{[3-(4-methylphenyl)-1H-pyrazol-4-yl]methylene}cyclohexanecarbohydrazide | 4-tert-butyl-N'-{[3-(4-methylphenyl)-1H-pyrazol-4-yl]methylene}cyclohexanecarbohydrazide | C22H30N4O
| | |
| 11 | | N,N-DIETHYL-2-[2-IMINO-3-(3-PHENOXYPROPYL)-2,3-DIHYDRO-1H-BENZIMIDAZOL-1-YL]-1-ETHANAMINE | N,N-DIETHYL-2-[2-IMINO-3-(3-PHENOXYPROPYL)-2,3-DIHYDRO-1H-BENZIMIDAZOL-1-YL]-1-ETHANAMINE | C22H30N4O
| | |
| 12 | 881743-64-2 | 奈妥吡坦中间体 | 3-PYRIDINECARBOXAMIDE, N-(1,1-DIMETHYLETHYL)-4-(2-METHYLPHENYL)-6-(4-METHYL-1-PIPERAZINYL)- | C22H30N4O
| | |